Inactive Instrument

Innovate Biopharmaceuticals Inc Stock Nasdaq

US61174L5012

Chart Innovate Biopharmaceuticals Inc

Duration

Period

Style

Dynamic Chart

Latest news about Innovate Biopharmaceuticals Inc

North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	Nov. 28	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 26	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 06	CI
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 02	CI
North American Morning Briefing : Stock Futures -2-	23-09-22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	23-09-15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	23-09-08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	23-09-01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	23-08-25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	23-08-18	DJ
North American Morning Briefing : Stock Futures -2-	23-08-11	DJ
Illumina cuts annual profit forecast as biotech funding woes linger	23-08-09	RE
Illumina cuts annual profit forecast	23-08-09	RE

More news

Analyst Recommendations on Innovate Biopharmaceuticals Inc

North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	23-09-08	DJ
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	23-05-18	MT
Truist Downgrades 9 Meters Biopharma to Hold From Buy	23-03-20	MT
Citigroup Initiates Coverage on 9 Meters Biopharma With Neutral Rating, $2.70 Price Target	23-02-13	MT
Oppenheimer Adjusts 9 Meters Biopharma Price Target to $51 From $5, Maintains Outperform Rating	22-11-02	MT

More recommendations

Press releases Innovate Biopharmaceuticals Inc

Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	23-10-02	AQ
9 METERS BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)	23-05-30	AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)	23-05-22	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-06	AQ

More press releases

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Sector

Investment Holding Companies

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+103.83%	4.45B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	981M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.88%	853M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+26.89%	560M

Shell Companies

Sales 2021	-	Sales 2022	-	Capitalization	16.32M
Net income 2021	-36M	Net income 2022	-43M	EV / Sales 2021	-
Net cash position 2021	46.83M	Net Debt 2022	7.08M	EV / Sales 2022	-
P/E ratio 2021	-6.47 x	P/E ratio 2022	-0.37 x	Employees	-
Yield 2021 *	-	Yield 2022	-	Free-Float	98.29%